Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

A short peptide derived from the gN helix domain of FGF8b suppresses the growth of human prostate cancer cells.

Li T, Luo W, He D, Wang R, Huang Y, Zeng X, Wang W, Chen X, Gao S, Yu Y, Li X, Wu X.

Cancer Lett. 2013 Oct 10;339(2):226-36. doi: 10.1016/j.canlet.2013.06.001. Epub 2013 Jun 14.

PMID:
23774400
2.

Screening a phage display library for a novel FGF8b-binding peptide with anti-tumor effect on prostate cancer.

Wang W, Chen X, Li T, Li Y, Wang R, He D, Luo W, Li X, Wu X.

Exp Cell Res. 2013 May 1;319(8):1156-64. doi: 10.1016/j.yexcr.2013.02.007. Epub 2013 Mar 4.

PMID:
23466786
3.

Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.

Nilsson EM, Brokken LJ, Härkönen PL.

Exp Cell Res. 2010 Mar 10;316(5):800-12. doi: 10.1016/j.yexcr.2009.11.019. Epub 2009 Dec 4.

PMID:
19962979
4.

Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.

Nilsson EM, Brokken LJ, Narvi E, Kallio MJ, Härkönen PL.

Mol Cell Endocrinol. 2012 Jul 6;358(1):104-15. doi: 10.1016/j.mce.2012.03.009. Epub 2012 Mar 23.

PMID:
22465097
5.

FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation.

Lui VW, Yau DM, Cheung CS, Wong SC, Chan AK, Zhou Q, Wong EY, Lau CP, Lam EK, Hui EP, Hong B, Hui CW, Chan AS, Ng PK, Ng YK, Lo KW, Tsang CM, Tsui SK, Tsao SW, Chan AT.

Oncogene. 2011 Mar 31;30(13):1518-30. doi: 10.1038/onc.2010.529. Epub 2010 Nov 29.

PMID:
21119603
6.

Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.

MacManus CF, Pettigrew J, Seaton A, Wilson C, Maxwell PJ, Berlingeri S, Purcell C, McGurk M, Johnston PG, Waugh DJ.

Mol Cancer Res. 2007 Jul;5(7):737-48. Epub 2007 Jul 2.

7.

A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions.

Maruyama-Takahashi K, Shimada N, Imada T, Maekawa-Tokuda Y, Ishii T, Ouchi J, Kusaka H, Miyaji H, Akinaga S, Tanaka A, Shitara K.

Prostate. 2008 May 1;68(6):640-50. doi: 10.1002/pros.20728.

PMID:
18213631
8.

Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells.

Chen LH, Fang J, Sun Z, Li H, Wu Y, Demark-Wahnefried W, Lin X.

J Nutr. 2009 Apr;139(4):653-9. doi: 10.3945/jn.108.101832. Epub 2009 Feb 11.

9.

Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.

Banudevi S, Senthilkumar K, Sharmila G, Arunkumar R, Vijayababu MR, Arunakaran J.

Clin Chim Acta. 2010 Feb;411(3-4):172-8. doi: 10.1016/j.cca.2009.10.023. Epub 2009 Nov 11.

PMID:
19913001
10.

Functional interaction of fibroblast growth factor 8b and androgen in prostate cancer cell proliferation.

Xiao WJ, Zhang GM, Ye DW.

Tumour Biol. 2017 Mar;39(3):1010428317695969. doi: 10.1177/1010428317695969.

PMID:
28345462
11.

[Molecular mechanism of FGF8b regulation of epithelial-mesenchymal transition in prostate cancer cells].

Fan B, Wang G, Qi F, Li Z, Liu H.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Jul;37(7):656-61. doi: 10.3969/j.issn.1672-7347.2012.07.002. Chinese.

12.

Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis.

Lin F, Lin P, Zhao D, Chen Y, Xiao L, Qin W, Li D, Chen H, Zhao B, Zou H, Zheng X, Yu X.

Cell Prolif. 2012 Jun;45(3):207-16. doi: 10.1111/j.1365-2184.2012.00812.x. Epub 2012 Apr 2.

PMID:
22469032
13.
14.

Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.

Liu Y, Hock JM, Sullivan C, Fang G, Cox AJ, Davis KT, Davis BH, Li X.

J Cell Biochem. 2010 Dec 15;111(6):1546-55. doi: 10.1002/jcb.22886.

PMID:
20862710
15.

Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.

Weiss-Messer E, Merom O, Adi A, Karry R, Bidosee M, Ber R, Kaploun A, Stein A, Barkey RJ.

Mol Cell Endocrinol. 2004 May 31;220(1-2):109-23.

PMID:
15196705
16.
17.

Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.

Manohar SM, Padgaonkar AA, Jalota-Badhwar A, Rao SV, Joshi KS.

Prostate Cancer Prostatic Dis. 2012 Mar;15(1):15-27. doi: 10.1038/pcan.2011.51. Epub 2011 Nov 15.

PMID:
22083267
18.

A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cells.

Morad SA, Schmid M, Büchele B, Siehl HU, El Gafaary M, Lunov O, Syrovets T, Simmet T.

Mol Pharmacol. 2013 Feb;83(2):531-41. doi: 10.1124/mol.112.081349. Epub 2012 Dec 3.

19.

Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.

Chen J, Zeng J, Xin M, Huang W, Chen X.

Horm Metab Res. 2011 Sep;43(10):681-6. doi: 10.1055/s-0031-1286306. Epub 2011 Sep 19.

PMID:
21932171
20.

Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.

Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH.

Oncogene. 2001 May 24;20(23):2927-36.

Supplemental Content

Support Center